Related Experiment Video
Updated: Jul 6, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
PIK3CA, HRAS and KRAS gene mutations in human penile cancer
Patiyan Andersson1, Aleksandra Kolaric, Torgny Windahl
1Division of Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden. patan@ibk.liu.se <e-mail:patan@ibk.liu.se>
Purpose:
The knowledge of somatic mutations that arise in penile cancer is limited. We examined the dysregulation of components in the phosphatidylinositol 3-kinase and Ras pathways.
Materials And Methods:
Using single stranded conformational analysis and direct sequencing we performed mutational analysis of the PIK3CA, PTEN, HRAS, KRAS, NRAS and BRAF genes in 28 penile tumors.
Results:
We identified somatic missense mutations in 11 of the 28 penile cancer samples (39%). In the PIK3CA gene 8 mutations (29%) were identified that were E542K or E545K. In the HRAS gene a G12S and a Q61L mutation were found (7%). The KRAS gene contained 1 mutation (3%), that is a G12S change. PIK3CA mutations were found in all grades and stages, whereas HRAS and KRAS mutations were found in larger and more advanced tumors. The mutations were mutually exclusive, suggesting that dysregulation of either pathway is sufficient for the development and progression of penile carcinoma.
Conclusions:
The high frequency of mutations in the PIK3CA, HRAS and KRAS genes leads us to believe that dysregulation of the phosphatidylinositol 3-kinase or Ras pathway is significant for the development and progression of penile carcinoma.
Insights
Somatic mutations in phosphatidylinositol 3-kinase (PIK3CA) and Ras (HRAS, KRAS) pathways are frequent in penile cancer. These genetic alterations are significant drivers for penile carcinoma development and progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Penile cancer is a rare malignancy with limited understanding of its underlying genetic landscape.
- Somatic mutations in key signaling pathways are crucial for cancer development.
Purpose of the Study:
- To investigate the frequency and spectrum of mutations in the phosphatidylinositol 3-kinase (PI3K) and Ras signaling pathways in penile cancer.
- To identify specific genes within these pathways that are dysregulated in penile tumors.
Main Methods:
- Mutational analysis of PIK3CA, PTEN, HRAS, KRAS, NRAS, and BRAF genes.
- Utilized single-stranded conformational analysis and direct sequencing techniques.
- Analyzed a cohort of 28 penile tumor samples.
Main Results:
- Somatic mutations were identified in 39% of penile cancer samples.
- PIK3CA mutations (E542K, E545K) were found in 29% of tumors across all grades and stages.
- HRAS and KRAS mutations (G12S, Q61L) were observed in 7% and 3% of tumors, respectively, and were associated with advanced stages.
Conclusions:
- Dysregulation of the PI3K and Ras pathways, driven by mutations in PIK3CA, HRAS, and KRAS, plays a significant role in penile cancer.
- The observed mutual exclusivity of mutations suggests that alterations in either pathway are sufficient for tumorigenesis.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
